653 related articles for article (PubMed ID: 19242239)
1. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.
Auletta JJ; Cooke KR
Curr Opin Pediatr; 2009 Feb; 21(1):30-8. PubMed ID: 19242239
[TBL] [Abstract][Full Text] [Related]
2. Graft-versus-host disease: a complex long-term side effect of hematopoietic stem cell transplant.
Barton-Burke M; Dwinell DM; Kafkas L; Lavalley C; Sands H; Proctor C; Johnson E
Oncology (Williston Park); 2008 Oct; 22(11 Suppl Nurse Ed):31-45. PubMed ID: 19856578
[TBL] [Abstract][Full Text] [Related]
3. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
[TBL] [Abstract][Full Text] [Related]
4. Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease.
Badillo AT; Peranteau WH; Heaton TE; Quinn C; Flake AW
Br J Haematol; 2008 Apr; 141(2):224-34. PubMed ID: 18318768
[TBL] [Abstract][Full Text] [Related]
5. Immune restoration following hematopoietic stem cell transplantation: an evolving target.
Auletta JJ; Lazarus HM
Bone Marrow Transplant; 2005 May; 35(9):835-57. PubMed ID: 15778723
[TBL] [Abstract][Full Text] [Related]
6. Current and novel therapies in acute GVHD.
Ho VT; Cutler C
Best Pract Res Clin Haematol; 2008 Jun; 21(2):223-37. PubMed ID: 18503988
[TBL] [Abstract][Full Text] [Related]
7. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
8. Management of acute graft-versus-host disease.
Bacigalupo A
Br J Haematol; 2007 Apr; 137(2):87-98. PubMed ID: 17391488
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis and treatment of acute graft-versus-host disease: current state, implications of new immunopharmacologic compounds and future strategies to prevent and treat acute GVHD in high-risk patients.
Deeg HJ
Bone Marrow Transplant; 1994; 14 Suppl 4():S56-60. PubMed ID: 7728127
[TBL] [Abstract][Full Text] [Related]
10. OTI-010 Osiris Therapeutics/JCR Pharmaceuticals.
Taupin P
Curr Opin Investig Drugs; 2006 May; 7(5):473-81. PubMed ID: 16729725
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus in hematopoietic stem cell transplantation.
Fortune K; Couriel D
Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):835-41. PubMed ID: 19545215
[TBL] [Abstract][Full Text] [Related]
12. Ocular graft-versus-host disease: a review.
Shikari H; Antin JH; Dana R
Surv Ophthalmol; 2013; 58(3):233-51. PubMed ID: 23541042
[TBL] [Abstract][Full Text] [Related]
13. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
[TBL] [Abstract][Full Text] [Related]
14. Graft-versus-host disease: review and nursing implications.
Mattson MR
Clin J Oncol Nurs; 2007 Jun; 11(3):325-8. PubMed ID: 17623617
[TBL] [Abstract][Full Text] [Related]
15. Graft-versus-host disease: emerging concepts in prevention and therapy.
Dean RM; Bishop MR
Curr Hematol Rep; 2003 Jul; 2(4):287-94. PubMed ID: 12901325
[TBL] [Abstract][Full Text] [Related]
16. Cardiac manifestations of graft-versus-host disease.
Rackley C; Schultz KR; Goldman FD; Chan KW; Serrano A; Hulse JE; Gilman AL
Biol Blood Marrow Transplant; 2005 Oct; 11(10):773-80. PubMed ID: 16182178
[TBL] [Abstract][Full Text] [Related]
17. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT.
Ruutu T; Niederwieser D; Gratwohl A; Apperley JF
Bone Marrow Transplant; 1997 Apr; 19(8):759-64. PubMed ID: 9134165
[TBL] [Abstract][Full Text] [Related]
18. Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Duran-Struuck R; Reddy P
Transplantation; 2008 Feb; 85(3):303-8. PubMed ID: 18301323
[TBL] [Abstract][Full Text] [Related]
19. Emerging drugs for acute graft-versus-host disease.
Khaled Y; Reddy P; Krijanovski O
Expert Opin Emerg Drugs; 2009 Jun; 14(2):219-32. PubMed ID: 19519285
[TBL] [Abstract][Full Text] [Related]
20. [Towards the use of intravenous apoptotic leukocyte infusion as a cell-based therapy approach?].
Saas P; Bonnefoy F; Kleinclauss F; Sun Y; Tiberghien P; Gaugler B; Perruche S
Transfus Clin Biol; 2008 Jun; 15(3):98-108. PubMed ID: 18524660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
